Selective vasopressin V1A receptor antagonist. Inhibits vasopressin and oxytocin-induced increases in intracellular calcium concentrations in vitro (IC50 values are 5 and 30 nM respectively). Exhibits potent and prolonged antivasopressor activity and induces anxiolytic-like effects in the dorsal, but not ventral, hippocampus in vivo.

73168-24-8

C52H74N14O12S2

1151.38

H2O:2 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years